These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 22045356)

  • 21. Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma.
    Chiang YC; Lin HW; Chang CF; Chang MC; Fu CF; Chen TC; Hsieh SF; Chen CA; Cheng WF
    Oncotarget; 2015 Nov; 6(37):39740-55. PubMed ID: 26452028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of advanced ovarian cancer recurrence by plasma metabolic profiling.
    Zhang H; Ge T; Cui X; Hou Y; Ke C; Yang M; Yang K; Wang J; Guo B; Zhang F; Lou G; Li K
    Mol Biosyst; 2015 Feb; 11(2):516-21. PubMed ID: 25424060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formyl peptide receptor 2 expression predicts poor prognosis and promotes invasion and metastasis in epithelial ovarian cancer.
    Xie X; Yang M; Ding Y; Yu L; Chen J
    Oncol Rep; 2017 Dec; 38(6):3297-3308. PubMed ID: 29039544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic values of 5-hmC, 5-mC and TET2 in epithelial ovarian cancer.
    Zhang LY; Li PL; Wang TZ; Zhang XC
    Arch Gynecol Obstet; 2015 Oct; 292(4):891-7. PubMed ID: 25827305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Molecular Landscape Influencing Prognoses of Epithelial Ovarian Cancer.
    Liu CL; Yuan RH; Mao TL
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epithelial ovarian cancer: the molecular genetics of epithelial ovarian cancer.
    Krzystyniak J; Ceppi L; Dizon DS; Birrer MJ
    Ann Oncol; 2016 Apr; 27 Suppl 1(Suppl 1):i4-i10. PubMed ID: 27141069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prognostic regulatory pathway in stage I epithelial ovarian cancer: new hints for the poor prognosis assessment.
    Calura E; Paracchini L; Fruscio R; DiFeo A; Ravaggi A; Peronne J; Martini P; Sales G; Beltrame L; Bignotti E; Tognon G; Milani R; Clivio L; Dell'Anna T; Cattoretti G; Katsaros D; Sartori E; Mangioni C; Ardighieri L; D'Incalci M; Marchini S; Romualdi C
    Ann Oncol; 2016 Aug; 27(8):1511-9. PubMed ID: 27194815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spy1 participates in the proliferation and apoptosis of epithelial ovarian cancer.
    Lu S; Liu R; Su M; Wei Y; Yang S; He S; Wang X; Qiang F; Chen C; Zhao S; Zhang W; Xu P; Mao G
    J Mol Histol; 2016 Feb; 47(1):47-57. PubMed ID: 26644004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis.
    Li F; Tie R; Chang K; Wang F; Deng S; Lu W; Yu L; Chen M
    BMC Cancer; 2012 Jun; 12():258. PubMed ID: 22712526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
    Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
    Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer.
    Huang B; Yin M; Li X; Cao G; Qi J; Lou G; Sheng S; Kou J; Chen K; Yu B
    Oncotarget; 2016 May; 7(19):27552-66. PubMed ID: 27050277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Diagnostic and Prognostic Potential of microRNAs in Epithelial Ovarian Carcinoma.
    Samuel P; Carter DR
    Mol Diagn Ther; 2017 Feb; 21(1):59-73. PubMed ID: 27718164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-infiltrating cytotoxic T lymphocytes as independent prognostic factor in epithelial ovarian cancer with wilms tumor protein 1 overexpression.
    Vermeij R; de Bock GH; Leffers N; Ten Hoor KA; Schulze U; Hollema H; van der Burg SH; van der Zee AG; Daemen T; Nijman HW
    J Immunother; 2011; 34(6):516-23. PubMed ID: 21654520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer.
    Ma R; Ye X; Cheng H; Ma Y; Cui H; Chang X
    Gynecol Oncol; 2015 Jun; 137(3):546-52. PubMed ID: 25735255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - a study of the OVCAD consortium.
    Pils D; Bachmayr-Heyda A; Auer K; Svoboda M; Auner V; Hager G; Obermayr E; Reiner A; Reinthaller A; Speiser P; Braicu I; Sehouli J; Lambrechts S; Vergote I; Mahner S; Berger A; Cacsire Castillo-Tong D; Zeillinger R
    Eur J Cancer; 2014 Jan; 50(1):99-110. PubMed ID: 24176298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear survivin is associated with malignant potential in epithelial ovarian carcinoma.
    Qian X; Xi X; Li L
    Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):126-32. PubMed ID: 20724919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancer.
    Hsu KF; Shen MR; Huang YF; Cheng YM; Lin SH; Chow NH; Cheng SW; Chou CY; Ho CL
    Br J Cancer; 2015 Jul; 113(3):414-24. PubMed ID: 26158423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Pathology of Ovarian Epithelial Neoplasms: Predictive, Prognostic, and Emerging Biomarkers.
    Ordulu Z; Watkins J; Ritterhouse LL
    Clin Lab Med; 2024 Jun; 44(2):199-219. PubMed ID: 38821641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and prognostic significance of lost or decreased PDCD5 expression in human epithelial ovarian carcinomas.
    Zhang X; Wang X; Song X; Wei Z; Zhou C; Zhu F; Wang Q; Ma C; Zhang L
    Oncol Rep; 2011 Feb; 25(2):353-8. PubMed ID: 21165576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of glucose transporter-1 (GLUT-1) predicts poor prognosis in epithelial ovarian cancer.
    Cho H; Lee YS; Kim J; Chung JY; Kim JH
    Cancer Invest; 2013 Nov; 31(9):607-15. PubMed ID: 24164300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.